or Try an Advanced Search...

    Keratosis Stocks List

    Symbol Grade Name % Change
    ACRS B Aclaris Therapeutics, Inc. 5.43
    BHC C Bausch Health Companies Inc. 0.06
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Dermatology Acne Actinic Keratosis Atopic Dermatitis Biotechnology Chemical Substances Colitis Common Warts Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Hydrogen Hydrogen Peroxide

    Related ETFs - A few ETFs which own one or more of the above listed Keratosis stocks.

    Symbol Grade Name Weight
    IWC B iShares Microcap ETF 0.04
    IBBQ D Invesco Nasdaq Biotechnology ETF 0.02
    IBB D iShares Nasdaq Biotechnology Index Fund 0.02
    BIB F ProShares Ultra Nasdaq Biotechnology 0.02
    VHT D Vanguard Health Care ETF 0.0
    View all Keratosis ETFs...
    Compare ETFs
    Compare BIB to VHT Compare IBBQ to IBB Compare IWC to IBBQ

        Keratosis Stocks Recent News

        Date Stock Title
        Nov 20 ACRS Aclaris upgraded to overweight by Cantor on in-licensing deal
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
        Nov 20 ACRS Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
        Nov 19 ACRS Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
        Nov 19 ACRS Aclaris stock soars for second day on licensing deal, analyst upgrades
        Nov 19 ACRS Aclaris Therapeutics secures global rights to Biosion’s antibodies
        Nov 19 ACRS ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
        Nov 18 ACRS Aclaris stock rallies 53% amid licensing deal, Piper upgrade
        Nov 18 BHC US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
        Nov 18 ACRS Aclaris signs license deal for biologics assets
        Nov 18 ACRS Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
        Nov 18 ACRS Aclaris Therapeutics Announces $80 Million Private Placement
        Nov 18 ACRS Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
        Nov 18 BHC PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
        Nov 18 BHC Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Dermatology Acne Actinic Keratosis Atopic Dermatitis Biotechnology Chemical Substances Colitis Common Warts Contact Lens Dermatitis Diarrhea Eye Gastroenterology Gastrointestinal Generic Pharmaceutical Generic Pharmaceuticals Hair Removal Health Products Hydrogen Hydrogen Peroxide
        Keratosis

        Keratosis (from kerat- + -osis) is a growth of keratin on the skin or on mucous membranes stemming from keratinocytes, the prominent cell type in the epidermis. More specifically, it can refer to:

        actinic keratosis (also known as solar keratosis)
        chronic scar keratosis
        hydrocarbon keratosis
        keratosis pilaris (KP, also known as follicular keratosis)
        seborrheic keratosisActinic keratoses are pre-malignant growths. Seborrheic keratoses are not pre-malignant.

        More about Keratosis
        Browse All Tags